4SC-101

Vidofludimus(4SC-101; SC12267) is a novel immunosuppressive drug that inhibits DHODH; inhibits IL-17 secretion in vitro independently of effects on lymphocyte proliferation.


Cat. No.: EX-A546	Purity: >98%

	Chemical structure of 4SC-101

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	400	In-stock
500mg	600	In-stock
1g	850	In-stock
2g	1450	In-stock
5g	2685	In-stock
10g	3865	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Vidofludimus
CAS No.	717824-30-1
Purity	>98%
Formula	C20H18FNO4
Mol Weight	355.3596
State	solid powder
Solubility	Soluble in DMSO; >100mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder 4℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Fitzpatrick LR, et al. Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action. J Pharmacol Exp Ther. 2012 Sep;342(3):850-60. [2]. Fitzpatrick LR, et al. 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2010 Oct;16(10):1763-77.
CoA	CoA of 4SC-101

Smiles:	COC1=CC(=CC=C1)C1=CC=C(NC(=O)C2=C(CCC2)C(O)=O)C(F)=C1


		Search